CSL Behring expands Illinois plasma, albumin manufacturing facility
CSL Behring is set to commence operations in its newly expanded 140,000 square foot facility, which also recently was approved by the US FDA.
Archives for October 2, 2014
Nova Bio-Pharma wins US patent for vaccine stabilisation device aiming to eliminate cold chain distribution
Nova’s vaccine stabilisation device, which enables vaccines to be dried and stabilized across a wide range of temperatures, has been awarded a US patent, though one researcher questions the utility of the device.
New mAb biosimilars could cut EU healthcare costs by 25% says EGA
The EGA has called for more awareness surrounding the uptake of biosimilars in Europe after a report has shown upcoming products could cut healthcare provider spending by a quarter.
Novartis Meningitis vaccine scoops innovation prize
The UK has awarded the Prix Galien for innovation to Novartis for its Meningitis B vaccine, Bexsero.
Employee injured by "chemical reaction" at Life Technologies facility in US
One person was injured and sent to hospital after an accident at Life Technologies’ site in Eugene, Oregon on Wednesday.